Aplenzin biovail wellbutrin :: - Wi-Skies

Bupropion, sold under the brand names Wellbutrin and Zyban among others, is a medication primarily used to treat major depressive disorder and to support ...

 

Bupropion - AdisInsight

Generic competition to Wellbutrin® XL which began in 2006 is having an ... Under the agreement, Biovail will manufacture, supply and sell Aplenzin™ to ...

 

Drug Approval Package: Aplenzin (Bupropion Hydrobromide) NDA ...

7 Apr 2009 ... Aplenzin (Bupropion Hydrobromide) Extended-Release Tablets Company: Biovail Laboratories International Application No.: 022108

 

Aplenzin label - FDA

To report SUSPECTED ADVERSE REACTIONS, contact Biovail ..... daily dose ( 450 mg) of WELLBUTRIN XL (equivalent to 522 mg APLENZIN) Tablets. This.

 

Aplenzin™, The Only Single Tablet Once-Daily Treatment for ...

Aplenzin differs from other generic and branded bupropion antidepressants because ... Sanofi-aventis U.S., which licensed Aplenzin from Biovail Corporation in ...

 

UPDATE 1-U.S. FDA approves Biovail drug for depression | Reuters

23 Apr 2008 ... TO Aplenzin extended-release tablets for treating depression, ... the antidepressant Wellbutrin XL, which is manufactured by Biovail and sold by ...

 

Bupropion - Wikipedia

Bupropion, sold under the brand names Wellbutrin and Zyban among others, is a medication ..... mg extended-release bupropion as produced by Impax Laboratories for Teva and Biovail for GlaxoSmithKline. ... as a hydrobromide salt instead of a hydrochloride salt, to be sold under the name Aplenzin by Sanofi- Aventis.

 

Bupropion - DrugBank

Aplenzin ER, Tablet, extended release, 348 mg/1, Oral, Stat Rx USA, 2009-03-30 , Not ... Wellbutrin SR, Tablet, extended release, 100 mg, Oral, Biovail ...

 

Biovail Enters into Commercial Alliance for Aplenzin(TM) – Bausch ...

22 Dec 2008 ... Agreement Reached with sanofi aventis US; Biovail's Supply Price Ranges from 25% to 35% of Net Sales; Product Launch Anticipated in ...

 

Biovail Receives FDA Approval for Aplenzin (BVF-033) – Bausch ...

23 Apr 2008 ... TORONTO--(BUSINESS WIRE)--April 23, 2008--Biovail Corporation ... Drug Application (NDA) for Aplenzin(TM) (formerly known as BVF-033), ...